Gamida Cell Performance
| GMDADelisted Stock | USD 1.40 0.09 6.04% |
The company retains a Market Volatility (i.e., Beta) of -0.62, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Gamida Cell are expected to decrease at a much lower rate. During the bear market, Gamida Cell is likely to outperform the market. Gamida Cell right now retains a risk of 0.0%. Please check out Gamida Cell treynor ratio, skewness, rate of daily change, as well as the relationship between the value at risk and accumulation distribution , to decide if Gamida Cell will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Gamida Cell has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Gamida Cell is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 64.7 M |
Gamida |
Gamida Cell Relative Risk vs. Return Landscape
If you would invest 140.00 in Gamida Cell on September 13, 2024 and sell it today you would earn a total of 0.00 from holding Gamida Cell or generate 0.0% return on investment over 90 days. Gamida Cell is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Gamida, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Gamida Cell Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gamida Cell's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Gamida Cell, and traders can use it to determine the average amount a Gamida Cell's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GMDA |
Based on monthly moving average Gamida Cell is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gamida Cell by adding Gamida Cell to a well-diversified portfolio.
Gamida Cell Fundamentals Growth
Gamida Stock prices reflect investors' perceptions of the future prospects and financial health of Gamida Cell, and Gamida Cell fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Gamida Stock performance.
| Return On Equity | -11.04 | |||
| Return On Asset | -0.41 | |||
| Operating Margin | (26.80) % | |||
| Current Valuation | 70.28 M | |||
| Shares Outstanding | 132.64 M | |||
| Price To Earning | (3.97) X | |||
| Price To Book | 117.40 X | |||
| Price To Sales | 6.44 X | |||
| Revenue | 1.78 M | |||
| EBITDA | (70.62 M) | |||
| Cash And Equivalents | 55.06 M | |||
| Cash Per Share | 0.92 X | |||
| Total Debt | 82.94 M | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (79.12 M) | |||
| Earnings Per Share | (0.82) X | |||
| Total Asset | 102.19 M | |||
| Retained Earnings | (479.83 M) | |||
| Current Asset | 56.03 M | |||
| Current Liabilities | 9.55 M | |||
About Gamida Cell Performance
By analyzing Gamida Cell's fundamental ratios, stakeholders can gain valuable insights into Gamida Cell's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Gamida Cell has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Gamida Cell has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company was founded in 1998 and is headquartered in Jerusalem, Israel. Gamida Cell operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 166 people.Things to note about Gamida Cell performance evaluation
Checking the ongoing alerts about Gamida Cell for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Gamida Cell help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Gamida Cell is not yet fully synchronised with the market data | |
| Gamida Cell may become a speculative penny stock | |
| Gamida Cell has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.78 M. Net Loss for the year was (63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gamida Cell currently holds about 55.06 M in cash with (79.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92. |
- Analyzing Gamida Cell's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Gamida Cell's stock is overvalued or undervalued compared to its peers.
- Examining Gamida Cell's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Gamida Cell's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Gamida Cell's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Gamida Cell's stock. These opinions can provide insight into Gamida Cell's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Gamida Stock
If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |